Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Role of imatinib-sensitive tyrosine kinases in the pathogenesis of chronic myeloproliferative disorders

Role of imatinib-sensitive tyrosine kinases in the pathogenesis of chronic myeloproliferative disorders. Seminars in Oncology. 2007; 44(2 Suppl 2):S17-30.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.